Details of the Drug Formulaction

General Information of Drug Formulation (ID: F19259)

• Formulation Name: Risperidone 4 mg tablet
• Company: Aphena Pharma Solutions-Tennessee; McKesson; Mylan Pharamceuticals; NCS HealthCare of KY, Inc dba Vangard Labs

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Risperidone	(DMN6DXL)	Bipolar I disorder		Approved

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Carmellose sodium	(E00625)	Not Available	Disintegrant
Docusate sodium	(E00563)	23673837	Surfactant
FD&C blue no. 2	(E00446)	2723854	Colorant
Lactose monohydrate	(E00393)	104938	Binding agent; Diluent; Dry powder inhaler carrier; Lyophilization aid
Magnesium stearate	(E00208)	11177	lubricant
Silicon dioxide	(E00670)	Not Available	Anticaking agent; Opacifying agent; Viscosity-controlling agent
Sodium benzoate	(E00432)	517055	Antimicrobial preservative; lubricant
Sodium lauryl sulfate	(E00464)	3423265	Emulsifying agent; Modified-release agent; Penetration agent; Solubilizing agent; Surfactant; lubricant
Sunset yellow FCF	(E00255)	17730	Colorant
Titanium dioxide	(E00322)	26042	Coating agent; Colorant; Opacifying agent
Triacetin	(E00080)	5541	Humectant; Plasticizing agent; Solvent